These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15774734)
1. AIDS clinical trials. More woes for novel HIV prevention approach. Cohen J Science; 2005 Mar; 307(5716):1708. PubMed ID: 15774734 [No Abstract] [Full Text] [Related]
2. The trials of tenofovir trials. Lancet; 2005 Mar 26-Apr 1; 365(9465):1111. PubMed ID: 15799093 [No Abstract] [Full Text] [Related]
3. Women testing tenofovir for HIV prevention. AIDS Patient Care STDS; 2005 Feb; 19(2):128. PubMed ID: 15747428 [No Abstract] [Full Text] [Related]
4. Unethical clinical trials in Thailand: a community response. Jintarkanon S; Nakapiew S; Tienudom N; Suwannawong P; Wilson D Lancet; 2005 May 7-13; 365(9471):1617-8. PubMed ID: 15885287 [No Abstract] [Full Text] [Related]
5. The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community. Chua A; Ford N; Wilson D; Cawthorne P PLoS Med; 2005 Oct; 2(10):e346. PubMed ID: 16231979 [No Abstract] [Full Text] [Related]
6. Can AIDS drug also prevent HIV infection? AIDS Read; 2004 Jan; 14(1):14. PubMed ID: 14959699 [No Abstract] [Full Text] [Related]
7. Unethical clinical trials in Thailand: a community response. Loff B; Jenkins C; Ditmore M; Overs C; Barbero R Lancet; 2005 May 7-13; 365(9471):1618-9. PubMed ID: 15889464 [No Abstract] [Full Text] [Related]
9. AIDS drug trial turned away; protests by prostitutes in Cambodia ended Tenofovir testing. Cha AE Washington Post; 2006 May; ():A10, A14. PubMed ID: 16856292 [No Abstract] [Full Text] [Related]
10. A second chance for microbicides. Baleta A Lancet; 2007 Jul; 370(9581):17-8. PubMed ID: 17632853 [No Abstract] [Full Text] [Related]
11. HIV pre-exposure prophylaxis in injecting drug users. Karim SS Lancet; 2013 Jun; 381(9883):2060-2. PubMed ID: 23769217 [No Abstract] [Full Text] [Related]
12. Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(23):463-5. PubMed ID: 23760186 [TBL] [Abstract][Full Text] [Related]
13. AIDS. Promote HIV chemoprophylaxis research, don't prevent it. Grant RM; Buchbinder S; Cates W; Clarke E; Coates T; Cohen MS; Delaney M; Flores G; Goicochea P; Gonsalves G; Harrington M; Lama JR; MacQueen KM; Moore JP; Peterson L; Sanchez J; Thompson M; Wainberg MA Science; 2005 Sep; 309(5744):2170-1. PubMed ID: 16195446 [No Abstract] [Full Text] [Related]
14. Tenofovir gel--the new HIV prevention 'banker'? Bateman C S Afr Med J; 2007 Jul; 97(7):496, 498. PubMed ID: 17805450 [No Abstract] [Full Text] [Related]
15. Trial of antiretroviral for HIV prevention on hold. Ahmad K Lancet Infect Dis; 2004 Oct; 4(10):597. PubMed ID: 15470760 [No Abstract] [Full Text] [Related]
16. Tenofovir gel studied. AIDS Patient Care STDS; 2002 Aug; 16(8):401-2. PubMed ID: 12227991 [No Abstract] [Full Text] [Related]
17. Compassionate use for tenofovir. AIDS Patient Care STDS; 2000 Feb; 14(2):101-2. PubMed ID: 10743524 [No Abstract] [Full Text] [Related]
18. Response to Joep M. A. Lange. Ditmore M PLoS Med; 2005 Oct; 2(10):e347. PubMed ID: 16231980 [No Abstract] [Full Text] [Related]
19. Disinhibition and risk compensation: scope, definitions, and perspective. Hogben M; Liddon N Sex Transm Dis; 2008 Dec; 35(12):1009-10. PubMed ID: 18936724 [No Abstract] [Full Text] [Related]
20. Cambodia: can a drug provide some protection? Cohen J Science; 2003 Sep; 301(5640):1660-1. PubMed ID: 14500956 [No Abstract] [Full Text] [Related] [Next] [New Search]